- Home
- MGRC vs VERA Comparison
MGRC vs VERA Comparison
Compare MGRC & VERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGRC
- VERA
- Stock Information
- Founded
- MGRC 1979
- VERA 2016
- Country
- MGRC United States
- VERA United States
- Employees
- MGRC N/A
- VERA 82
- Industry
- MGRC Diversified Commercial Services
- VERA Biotechnology: Pharmaceutical Preparations
- Sector
- MGRC Consumer Discretionary
- VERA Health Care
- Exchange
- MGRC Nasdaq
- VERA Nasdaq
- Market Cap
- MGRC 3.0B
- VERA 1.8B
- IPO Year
- MGRC N/A
- VERA 2021
- Fundamental
- Price
- MGRC $127.18
- VERA $28.58
- Analyst Decision
- MGRC Buy
- VERA Buy
- Analyst Count
- MGRC 2
- VERA 8
- Target Price
- MGRC $145.50
- VERA $66.38
- AVG Volume (30 Days)
- MGRC 154.4K
- VERA 1.0M
- Earning Date
- MGRC 02-19-2025
- VERA 03-19-2025
- Dividend Yield
- MGRC 1.52%
- VERA N/A
- EPS Growth
- MGRC 32.46
- VERA N/A
- EPS
- MGRC 9.43
- VERA N/A
- Revenue
- MGRC $910,942,000.00
- VERA N/A
- Revenue This Year
- MGRC $12.09
- VERA N/A
- Revenue Next Year
- MGRC $1.26
- VERA N/A
- P/E Ratio
- MGRC $13.49
- VERA N/A
- Revenue Growth
- MGRC 9.51
- VERA N/A
- 52 Week Low
- MGRC $95.50
- VERA $25.99
- 52 Week High
- MGRC $129.93
- VERA $51.61
- Technical
- Relative Strength Index (RSI)
- MGRC 63.36
- VERA 29.57
- Support Level
- MGRC $119.18
- VERA $25.99
- Resistance Level
- MGRC $123.80
- VERA $34.79
- Average True Range (ATR)
- MGRC 2.94
- VERA 2.15
- MACD
- MGRC 0.34
- VERA -0.56
- Stochastic Oscillator
- MGRC 74.42
- VERA 20.05
About MGRC McGrath RentCorp
McGrath RentCorp is a rental company. It is comprised of four reportable business segments: Modular building and portable storage segment (Mobile Modular), Electronic test equipment segment (TRS-RenTelco), Containment solutions for the storage of hazardous and non-hazardous liquids and solids segment (Adler Tanks) and Classroom manufacturing division selling modular classrooms in California (Enviroplex). The company generates its revenues majorily from the rental of its equipment on operating leases with sales of equipment occurring in the normal course of business.
About VERA Vera Therapeutics Inc.
Vera Therapeutics Inc is a clinical stage biotechnology company. It is focused on developing and commercializing transformative treatments for patients with serious immunological diseases. The company's product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection once weekly that blocks both B lymphocyte stimulator and a proliferation-inducing ligand, which stimulate B cells and plasma cells to produce autoantibodies contributing to certain autoimmune diseases.